OMNI Institute

Millennials (persons born between 1981 and 1996) comprise a substantial and growing proportion of tourism consumers in the US. Rural economies, especially Native American communities, focused on casino revenue are faced with the challenge of sustainable economic growth in a millennial-dominant, post-COVID-19 pandemic economy. We estimate millennials’ willingness to pay for proposed cultural tourism scenarios using a discrete choice experiment on federally recognized tribal land in Arizona, US. We find strong preferences among millennials for guided recreational experiences, including horseback riding, hot spring visits, hiking, and cooking classes. With a changing demographic of potential visitors and a marked need to incorporate indigenous voices for the future of sustainable tourism, our results provide insight for future economic growth opportunities in cultural and natural resource tourism for Native American and rural communities.

The correct use of APRV provides alveolar opening for most of the respiratory cycle, reducing its movements and pulmonary stress, which reduces the mechanical power and the risk of damage caused by invasive mechanical ventilation. From its beginnings, to the present, ventilation with APRV has been criticized due to the results obtained in several research. Analyzing them, it can be seen that the application of this ventilation mode is not always adequate, interfering with its very objective. In this short-review, we describe the physiological foundations and the correct way to use APRV in intensive care patients, as well as the evidence that justifies the advantages and disadvantages of APVR.

Efforts to combat the global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) range from adequate diagnostic testing and contract tracing to vaccination for the prevention of coronavirus disease 2019 (COVID-19). In the United States alone, three vaccinations have been authorized for emergency use (EUA) or approved to prevent COVID-19. The Ad26.COV2.S vaccine by Johnson and Johnson (New Brunswick, New Jersey) is the only adenovirus-based vaccine and deemed relatively effective and safe by the US Food and Drug Administration (FDA) following its clinical trial. Since its introduction, the US FDA has placed a warning on the vaccine adverse event reporting system (VAERS) after more than 100 cases of Guillain-Barre Syndrome (GBS) were reported. Herein, we outline the hospital course of a generally healthy 49-year-old female who experienced an axonal form of GBS nine days after receiving the Ad26.COV2.S vaccine.

IntroductionCoronavirus disease 2019 (COVID-19) has become a global threat to public health. The current study investigates alterations in the biological estimates concerning the severity, recovery, mortality, and assessment of treatment-based outcomes.MethodsA case series of 165 COVID-19 patients admitted to OMI Institute (a tertiary care hospital) was conducted between May and August 2020. The data regarding demographic characteristics, comorbid conditions, radiographic abnormalities, biological estimations, symptoms, treatment, disease progression, complications, and outcomes were recorded using a structured questionnaire. Laboratory estimations included complete blood count (CBC), renal and electrolyte profile, liver function tests (LFTs), hematological indices, and inflammatory markers. Chest X-ray, electrocardiogram (ECG), and a high-resolution computed tomography (HRCT) scan were also performed, and data were extracted from the medical records. Analysis was done using the Statistical Package for the Social Sciences (SPSS) version 22.0.ResultsOut of the 165 COVID-19 patients, 79.4% recovered and were successfully discharged, while 20.6% of inpatient died. The patients' mean age was 56.03 ± 15.96 years, with a male majority (55.1%). The most common comorbid conditions were diabetes and hypertension; fever and dry cough were among the most frequently reported symptoms. The chest imaging findings among the severe/critical COVID-19 patients showed extensive bilateral patchy opacities. The median laboratory investigations, including neutrophil-to-lymphocyte ratio (NLR) (14.83), C-reactive protein (CRP) (7.4 mg/dl), lactate dehydrogenase (LDH) (786 IU/L), ferritin (1401.15 mcg/ml), and mean oxygen saturation (88.25%), were significantly altered among cases with increased disease severity and those who expired (p<0.05). The proportion of acute respiratory distress syndrome (ARDS) and sepsis development was significantly high among severe/critical COVID-19 patients (p<0.05). Treatment with tocilizumab, remdesivir, doxycycline, ivermectin, enoxaparin sodium, and steroids was deemed to be potentially effective treatment options in terms of reducing COVID-19 severity and chances of recovery. Furthermore, age (OR 1.05; p=0.047), presence of comorbidity (OR 8.471; p=0.004), high NLR, LDH (final outcome) (OR 1.361 and 1.018; p<0.05), and CRP levels (midpoint) (OR 1.631; p=0.05) were identified as the strong predictors of death among COVID-19 patients.ConclusionThe study identified several alterations in the clinical profile of the COVID-19 patients concerning severity during the hospital stay, affecting prognosis. Clinically, tocilizumab, remdesivir, doxycycline, ivermectin, enoxaparin sodium, and steroids were identified as potential therapeutic options for COVID-19 due to their ability to alter disease-associated severity and recovery rate.

ABSTRACTResearch Findings. A randomized controlled trial evaluated the impact of Motheread/Fatheread Colorado (MFC), an early childhood literacy intervention, on parent reading behaviors and their preschool-aged children’s literacy skills. Parents in the experimental condition participated in MFC; control parents did not. Dependent variables included measures of parental behavior supportive of reading in the home, and parent- and teacher-reported child literacy outcomes. Parents in the intervention group reported spending significantly more time reading with their children and a significantly greater use of interactive reading skills than parents in the control condition. Children in the intervention group scored significantly higher than children in the control group on parent-reported language and reading skills immediately following the intervention. There was no significant difference in immediate post-intervention teacher reports of child literacy skills. However, up to 15-months after program completion, children in the intervention condition had greater gains in teacher-reported language skills than children in the control condition. Results suggest that MFC is a promising intervention for changing the home literacy environment and children’s literacy outcomes. Practice/Policy. Motheread/Fatheread may be a good fit for organizations interested in implementing interventions aimed at improving home literacy for preschool-aged children.

Approximately 40% of adults aged 65 and older are affected by Chronic Kidney Disease (CKD). Anemia is an associated symptom seen in many patients diagnosed with CKD, promoting elevated cardiovascular risk, decreased quality of life, and increased morbidity and mortality in affected populations. Hepcidin‐25 (hepcidin) is a key iron regulating hormone secreted by hepatocytes to regulate and maintain body iron homeostasis and dietary iron absorption. Hepcidin does this by stifling iron release from macrophages, preventing the normal recycling of iron in the body needed to support erythropoiesis. Elevated levels of hepcidin have been observed in both adults and children suffering from CKD, while its pathological mechanism of action is still relatively unstudied. There is a growing need to further the understanding of hepcidin's role in CDK and other iron related pathologies. Currently there is no standardized methodology for hepcidin evaluation studies on relevant human cell lines, and there is a growing need for studies to be done in this field to assist biomedical researchers in the translation of clinically relevant lab findings from the benchtop to the bedside. Hep G2 is a perpetual human hepatic cancer cell line confirmed to produce hepcidin and a commonly used lineage when studying hepatic function in vitro. While it is confirmed that Hep G2 cells produce hepcidin when cultured, there is currently no standardized procedure for detection of this peptide in vitro from these, or any other human derived cell lines. The expanding clinical and biomedical implications of hepcidin has prompted the need to determine an optimal method for detection of hepcidin in vitro. In this study we use of Hep G2 cells as a model for hepcidin peptide detection and various tissue processing techniques to prepare the cells hepcidin quantification via ELISA.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

ABSTRACTThe US Surgeon General recently issued a comprehensive report indicating that substance use is a major public health concern that must be addressed using a number of strategies. Screening, brief intervention, and referral to treatment (SBIRT) is one such strategy. SBIRT Colorado, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA), has implemented a statewide initiative for the past 10 years that has provided ample opportunities to identify key components for successful implementation. Successful implementation requires (1) strong clinical and management advocates; (2) full integration of services into practices' workflow utilizing technology whenever possible; (3) interprofessional team approaches; (4) appropriate options for the small proportion of patients screening positive for a possible substance use disorder; (5) cannabis screening that accounts for legalization, and interventions that acknowledge differences between alcohol and cannabis use; (6) incorporating SBIRT into standard health care professionals' training; and (7) addressing the significant issues regarding reimbursement through private and public payers for SBIRT services. Implementing and sustaining SBI as a standard of integrated care is essential to reduce the burden of substance use. Interdisciplinary approaches, technology, and training to increase practitioner confidence and skill are fundamental.

We evaluated an intervention to increase participant retention and engagement in community practice settings of the Nurse-Family Partnership (NFP), an evidence-based program of nurse home visiting for low-income, first-time parents. Using a quasi-experimental design (6 intervention and 11 control sites that delivered the NFP), we compared intervention and control sites on retention and number of completed home visits during a 10-month period after the intervention was initiated. Nurses at the five intervention sites were guided in tailoring the frequency, duration, and content of the visits to participants' needs. NFP nurses at the control sites delivered the program as usual. At the intervention sites, participant retention and completed home visits increased from the pre-intervention to intervention periods, while at the control sites, these outcomes decreased from the pre-intervention to intervention periods, leading to a significant intervention-control difference in change in participant retention (hazard ratio, 0.42; p = 0.015) and a 1.4 visit difference in change in completed home visits (p < 0.001, ES = 0.36). We conclude that training nurse home visitors to promote adaptation of program dosage and content to meet families' needs shows promise as a way to improve participant retention and completed home visits.

Sharp, (1991) reported that at least 109 infants in Nigeria have died due to failure to follow GMP.This was caused due to the supply of mislabeled ethylene glycol as propylene glycol.This mislabeled material was then supplied to a pharmaceutical manufacturer.The manufacturer failed to perform adequate incoming quality control identification and Preventable adverse events Injury or death Product quality defects Medication errors Remaining uncertainties  Un-expected side effects  Unstudied uses  Unstudied populations Known side effects Unavoidable Avoidable GMP www.intechopen.comPromising Pharmaceuticals 104potency tests and final product evaluation did not pick up the problem.This has resulted due to failure in following GMP norms in manufacturing drugs.The effective implementation of GMP would prevent this mistake.There was an incident of the outbreak of diethylene glycol poisoning that occurred in Haiti from November 1995 to June 1996 due to contamination of glycerol with diethylene glycol used in the preparation of paracetamol syrup.The incident led to some 89 deaths of children from Kidney failure.This was notified by the WHO through its newsletter no.10th Oct. 1996.The cause of fetal incident once again became the same deadly poisonous chemical diethylene glycol which casued the death of 107 people way back in 1937.The outbreak in Haiti emphasizes the need for pharmaceutical manufacturers' world wide to be aware of possible contamination of glycerol and other raw materials with diethylene glycol and to use appropriate quality control measure to identify and prevent potential contamination.This also has strengthened the enforcement of GMP guidelines to ensure safety and efficacy of the pharmaceutical products.Effective implementation of GMP would also provide the cost benefit to the manufacturers, by avoiding the cost of failures such as cost of waste, of rework, of recall, of consumer compensation, of company reputation, and of regulatory action suspending operations.Documentation, Production, Quality control, Contract manufacturing and analysis, Complaints and Product recall and Self Inspection as basic requirements of GMP with 14 annexes.Currently the guide is presented in three parts and supplemented with a series of annexes.Part I covers basic requirements for medicinal products, Part II covers basic requirements for active substances used as starting materials and Part III contains GMP related documents, which clarify the regulatory expectations (EudraLex, 2012).Pharmaceutical inspection convention/Pharmaceutical Inspection Co-operation Scheme (PIC/S) had published PE 009-2 Guide to GMP for medicinal products in 2004.In order to further facilitate the removal of barriers to trade in medicinal products, to promote uniformity in licensing decisions and to ensure the maintaining of high standards of quality assurance in the development, manufacture and control of medicinal products throughout Europe, it was agreed to harmonize the rules of GMP applied under Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) to those of the EU Guide to Good Manufacturing Practice for Medicinal Products and its Annexes.The guide contains nine chapters describing Quality management, Personnel, Premises and Equipment, Documentation, Production, Quality control, Contract manufacturing and analysis, Complaints and Product recall and Self Inspection with 18 annexes.US FDA ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its cGMP regulations.Section 21 of the CFR contains most regulations pertaining to food and drugs.The regulations document the actions of drug sponsors that are required under Federal law.21 CFR Part 210.cGMP in manufacturing processing, packing, or holding of drugs.21 CFR Part 211.cGMP for finished pharmaceuticals.The CFR 21 part 211 dealing with cGMP for finished pharmaceuticals consists of Subparts A to K describing different components as General Provisions, Organization and Personnel, Building and Facilities, Equipment, Control of Components and Drug Product Containers and Closures, Production and Process Controls, Packaging and Labeling Control, Holding and Distribution, Laboratory Controls, Records and Reports and Returned and Salvaged Drug Products (Revised as of April 1, 2011).